Clinical trial
Efficacy of Diamel in the Treatment of Metabolic Syndrome
NCT01025115 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Diamel in the Treatment of Metabolic Syndrome
- Lead sponsor
- Catalysis SL
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- March 31, 2010
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.